Suspended
A Multiple-Center, Randomized, Double-Blind Study of Comparison of Risperidone and Aripiprazole for Treatment
What is being tested
Aripiprazole
+ Risperidone
Drug
Who is being recruted
From 19 to 65 Years
+8 Eligibility Criteria
How is the trial designed
Treatment Study
Phase 4
Interventional
Study Start: July 2012
Summary
Principal SponsorWei Hao
Last updated: February 4, 2015
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 2012
Actual date on which the first participant was enrolled.Methods:A Multiple-Center, Randomized, Double-Blind.
Principal SponsorWei Hao
Last updated: February 4, 2015
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Any sex
Biological sex of participants that are eligible to enroll.From 19 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
3 inclusion criteria required to participate
Must sign a Information consent form
Patients,Diagnostic and Statistical Manual of Mental Disorders 4thed. (DSM-IV) criteria for Methamphetamine-Associated Psychosis
Required to provide detailed address and phone number
5 exclusion criteria prevent from participating
Serious organic disease
Suicide ideation or hurt others
Taking antipsychotic within two weeks before
drug allergy to Risperidone or Aripiprazole
Show More Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalAripiprazole arm,5mg/pill,20-30mg/day,non-forced titration method.last2-4weeks.
Group II
Active ComparatorRisperidone arm and placebo tables,1mg/pill,2mg-6mg/day,non-forced titration method.last2-4weeks.
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
The Second Xiangya Hospital of Central University
Changsha, ChinaOpen The Second Xiangya Hospital of Central University in Google MapsSuspendedOne Study Center